TLR - possible molecular target for biologic psoriasis therapy
- Authors: Katunina OR1, Rezaykina AV1
-
Affiliations:
- Issue: Vol 88, No 3 (2012)
- Pages: 55-57
- Section: Articles
- Submitted: 11.03.2020
- Published: 15.06.2012
- URL: https://vestnikdv.ru/jour/article/view/684
- DOI: https://doi.org/10.25208/vdv684
- ID: 684
Cite item
Full Text
Abstract
Target: studies of 2, 4, 9 types of TLR in the affected skin of patients with psoriasis with evaluation of morphometric indices. Маterial and methods. Immunohistochemical skin research at 15 patients, suffering from psoriasis (12 women and 18 men) in the age of 19-68 y.o. and at 10 healthy trial subjects. Results. The increased expression of TLR2 и TLR4 was revealed in the skin patients, suffering from psoriasis. Opinions. This fact enlarges considerably psoriasis pathogenesis perceptions and determines the new vector of research, forwarded to the search of the ethologic factor, as well as the optimization of existing methods of the systemic psoriasis therapy.
Full Text
Толл-подобные рецепторы - возможная молекулярная мишень для биологической терапии псориаза×
References
- Janeway C.A., Medzhitov R. Innate immune recognition. Annu Rev Immunol- 2002; 20: 197-216.
- Kopp E.B., Medzhitov R. The Toll-receptor family and control of innate immunity. Curr Opin Immunol 1999; 11: 1: 13-28.
- von Andrian U H., Mackay C.B. T-cell function and migration: two sides of the same coin. N Engl J Med 2000; 343: 1020-1034.
- Takeuchi O., Akira S. Pattern Recognition Receptors and Inflammation. Cell 2010; 140: 805-820.